Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.
Eligible age
18–50 yrs
Accepts
Women
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary objective of our study is to determine the percentage of patients with endometriosis who are non-responsive to medical therapy after 12 months and to compare the clinical and ultrasound characteristics of this group of patients (study group) with the clinical and ultrasound characteristics of patients who are responsive to medical therapy (control group). The secondary objective of the study will be to determine the percentage of patients with endometriosis who are non-responsive to medical therapy after 6 months and to compare the clinical and ultrasound characteristics of this group of patients (study group) with the clinical and ultrasound characteristics of patients who are responsive to medical therapy (control group).
Sponsor: University of Cagliari
You may qualify if…
- ✓ Age between 18 and 50 years;
- ✓ Patients with painful symptoms related to endometriosis (dyspareunia, dyschezia, dysmenorrhea, chronic pelvic pain, dysuria, periovulatory pain, with at least one of these symptoms presenting a Numerical Pain Rating Scale intensity \> 5);
- ✓ Indication for the administration of oral hormonal medical therapy for endometriosis;
- ✓ Acquisition of informed consent.
You may not qualify if…
- ✕ Patients with contraindications to oral hormonal therapy;
- ✕ Current or past pelvic infections;
- ✕ History of malignancy or current suspicion of malignant gynecological lesions;
- ✕ Previous pelvic surgery (hysterectomy, salpingectomy, ovarian cyst removal, myomectomy, surgery for endometriosis, intestinal resections);
- ✕ Positive history for other causes of chronic pelvic pain;
- ✕ Postmenopausal status.
Source: ClinicalTrials.gov · NCT06510647 · last updated 2024-07-19